Volume 26, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Menichlopholan, a biphenyl compound, in a single dose of 2 mg/kg body weight, gave a 73%–90% cure rate in the treatment of pulmonary infections due to at two centers in Nigeria. Ninety-five patients were followed up for 4 months, and 58 for 1 year. Side effects of the drug included sweating and body pains, but there was no significant biochemical or hematological evidence of damage to the internal organs. The advantages of single dose therapy are likely to make menichlopholan the treatment of choice for paragonimiasis in Africa, and probably elsewhere.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...


Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error